Garuda Raises $50M Series A-1 For Blood Stem Cell Therapies
04 Mar 2025 //
GLOBENEWSWIRE
Garuda Therapeutics Names Avanish Vellanki As President & CEO
03 Mar 2025 //
GLOBENEWSWIRE
Garuda Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
09 Jan 2024 //
BUSINESSWIRE
Garuda Announces the Appointment of Panteli Theocharous as CTO
25 Oct 2023 //
BUSINESSWIRE